Gastroenterology Stocks
Specialized healthcare entities in this space focus on the diagnosis, management, and treatment of inflammatory, autoimmune, and metabolic disorders affecting the digestive tract and associated organs.
As of Oct 23, 2026, Gastroenterology has 32 US-listed companies worth $126B combined. The median member moved +0.4% over the past week; VOGX led among the 25 largest at +20.1% and PHAT trailed at -17.1%.
Companies in Gastroenterology
- TAK – Takeda Pharmaceutical Co Ltd ADR, $64.7B
- VTRS – Viatris Inc, $21.2B
- PTGX – Protagonist Therapeutics Inc, $9B
- SYRE – Spyre Therapeutics Inc., $8.7B
- ABVX – Abivax SA American Depositary Shares, $7.7B
- MIRM – Mirum Pharmaceuticals Inc, $5.3B
- BHC – Bausch Health Companies Inc, $2.4B
- CSTL – Castle Biosciences Inc, $1.1B
- ODTX – Odyssey Therapeutics, Inc. Common Stock, $871M
- ARDX – Ardelyx Inc, $842M
- IRWD – Ironwood Pharmaceuticals Inc, $620M
- PHAT – Phathom Pharmaceuticals Inc, $551M
- EPRX – Eupraxia Pharmaceuticals Inc. Common Stock, $493M
- YDES – YD Bio Ltd, $477M
- AGMB – AgomAb Therapeutics NV American Depositary Shares, $422M
- CV – CapsoVision, Inc. Common Stock, $361M
- PALI – Palisade Bio Inc, $251M
- VOGX – Vogenx Inc Common Stock, $216M
- EVMN – Evommune, Inc., $188M
- LUCD – Lucid Diagnostics Inc, $116M
- CPIX – Cumberland Pharmaceuticals Inc, $111M
- IMUX – Immunic Inc, $95.4M
- NRXS – Neuraxis, Inc., $87M
- ONCY – Oncolytics Biotech Inc, $71.8M
- IMRN – Immuron Ltd ADR, $9.4M
- BMRA – Biomerica Inc, $8.6M
- CURX – Curanex Pharmaceuticals Inc Common Stock, $7.5M
- JAGX – Jaguar Animal Health Inc, $6.9M
- EOCN – Eocene Ltd., $3.8M
- RDHL – Redhill Biopharma Ltd, $3M
- KLDO – Kaleido Biosciences Inc, $4,262
- MOTS – Motus GI Holdings Inc, $1,277